«

»

Mar 23

The European Congress on Osteoporosis & osteoarthritis is currently in Valencia.

Notes:.the European Congress on Osteoporosis & osteoarthritis is currently in Valencia, Spain and continued until 26Abstract 0C1: The Burden of Fractures in France, Germany, Italy, Spain, Sweden and the United Kingdom. M et al. Osteoporosis International.1007/s00198-011-1554-9Source: L.

At the European Congress on Osteoporosis & Osteoarthritis presented by investigators from the United Kingdom and Sweden, estimates that the economy in France, Germany, Italy, Spain, Sweden and the United Kingdom alone, the total cost of fragility fractures 31 billion euros burden of burden of fractures in five major European countries is 31 billion euros, with Germany to pay the highest cost. A large part of the economic burden is shown that the cost will be available during the first years after the breach costs, while pharmacological prevention and treatment management represents only a minor proportion of the total economic costs. Hip fractures contributed 56 percent to the total costs, vertebral fractures 5 percent, wrist fractures represent 2 percent and a combined group of other fractures, 37 percent of the total.The results of echoes earlier, a small study that in comparison ranibizumab own against ranibizumab and laser treatment or lasers solely, said Lim, who of the earlier study of the earlier study. In this study, after six months, ranibizumab a standalone eye and was best, ‘and we unreleased data which propose keeping the results at one year and nice,’she said. ‘Ranizumab an important new options for individuals with diabetes,’said Lim , director of the the retina services UIC is. She said that she hope the high complication of patients would be treated corticosteroid to use the use these outdated treat Displaying. Michael Blair, Alerts professor of ophthalmic and optic sciences, also acted as location principal investigator of degree.

Says Dr. Main cause of blindness among adultsA drug used can be more efficient against the leading cause of blindness adult than laser treatments a new study a new study.

The as a part of as part of the Diabetic Retinopathy Clinical Research Network and supported by National Eye Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases, both part of NIH.